Lilly is looking innovative approaches for immunologic diseases.
Pharma & Medical ProductsEli Lilly Finalizes Morphic AcquisitionEli Lilly Finalizes Morphic Acquisition
The acquisition will broadens Lilly's immunology pipeline with Morphic's oral integrin therapies.
Sign up for the Powder & Bulk Solids Weekly newsletter.